Year: 2023

In January 2023, SAMHSA announced that clinicians no longer need a federal waiver to prescribe buprenorphine for treating opioid use disorder. However, clinicians are still required to register with the Drug Enforcement Agency to prescribe controlled medications. Beginning June 27, 2023, new and renewing prescribers will have to confirm that they have completed a new, …

Recent projects have used the NIATx approach to explore coaching, how patients use mobile health apps, and how to recruit prescribers for medications for opioid use disorder (MOUD). Coaching as an implementation strategy What makes coaching effective for implementing a new practice or application?  To find out, the study team first interviewed nine experienced NIATx …